QA: Paratek Pharmaceuticals Inc in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2015_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 101,329,000
1 IntangibleAssetsNetIncludingGoodwill 5,643,000
2 PropertyPlantAndEquipmentNet 49,000
3 remainder_Assets 2,946,000
4 LiabilitiesCurrent 3,741,000
5 LiabilitiesNoncurrent 3,592,000
6 remainder_Liabilities 7,410,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,236,453
9 ResearchAndDevelopmentExpense 4,910,818
10 remainder_Expenses 1,927,819
11 remainder_Revenues -765,076
12 remainder_NetIncome -105,623
13 remainder_ComprehensiveNetIncome 7,780
  yvar yval
0 Assets 109,967,000
1 Liabilities 14,743,000
2 Expenses 14,075,090
3 Revenues -765,076
4 StockholdersEquity 95,224,000
5 NetIncome -14,945,789
6 ComprehensiveNetIncome -14,941,899
7 BaseVar 69,831,784
8 EconomicCapitalRatiobeforeLimitedLiability 3.09
9 EconomicCapitalRatio 3.75

Edgar->Model Mapping

Feature Distribution

Change over Time